Latest filing published 06 Dec 2023 for Fresh Tracks Therapeutics, Inc., €4,069.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Exploration Capital Fund, LP: trading record in brief
Exploration Capital Fund, LP is a declared insider of Fresh Tracks Therapeutics, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 4 December 2023 to 6 December 2023, the count stands at 3 filings.
The open-market record is one-sided, with 3 purchases worth €24k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
A typical purchase (the median) is worth €5,917. Across 3 purchases, this insider has always bought alone, with no colleague buying within 30 days.
On 6 December 2023 came the latest disclosure, an open-market purchase for €4,069 in Fresh Tracks Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Exploration Capital Fund, LP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,188 shares@ US$0.8516.7% of flowCommon StockSEC:0001213900-23-093858:1Canonical exit: 4 Mar 2024 (T+90)
- 17,233 shares@ US$0.9059.0% of flowCommon StockSEC:0001213900-23-093858:2Canonical exit: 5 Mar 2024 (T+90)
- 7,579 shares@ US$0.85100.0% of flowCommon StockSEC:0001213900-23-093858:0Canonical exit: 3 Mar 2024 (T+90)
3 of 3 declarations
